H. R. 3348
IN THE HOUSE OF REPRESENTATIVES
July 20, 2017
Mr. Peters (for himself, Mr. Brendan F. Boyle of Pennsylvania, Mr. Marshall, and Mr. Rothfus) introduced the following bill; which was referred to the Committee on Energy and Commerce
To expand the tropical disease product priority review voucher program to encourage treatments for the Middle East respiratory syndrome.
This Act may be cited as the
Adding Middle East Respiratory Syndrome to the FDA Priority Review Voucher Program Act.
Expanding tropical disease product priority review voucher program to encourage treatments for Middle East respiratory syndrome
Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n(a)(3)) is amended—
by redesignating subparagraph (S) as subparagraph (T); and
by inserting after subparagraph (R) the following:
Middle East respiratory syndrome.